Upfront immunotherapy for synchronous high-grade glioma and B-lymphoma
in a pediatric patient with CMMRD syndrome.
- Thérèse de Vanssay,
- Nour El Riachy,
- Caroline Donzé
, - Romain Appay,
- Didier Scavarda,
- Benoit Testud,
- Nicolas André,
- Gabriel Revon-Riviere
Nour El Riachy
Aix-Marseille Universite Bibliotheque Universitaire Pharmacie
Author ProfileCaroline Donzé
Nationwide Children's Hospital Hematology Oncology & Blood and Marrow Transplant
Author ProfileRomain Appay
Aix-Marseille Universite Bibliotheque Universitaire Pharmacie
Author ProfileDidier Scavarda
Orlando Health Arnold Palmer Hospital for Children Department of Pediatric Neurosurgery
Author ProfileBenoit Testud
King's College Hospital Department of Neuroradiology
Author ProfileNicolas André
Nationwide Children's Hospital Hematology Oncology & Blood and Marrow Transplant
Author ProfileGabriel Revon-Riviere
Nationwide Children's Hospital Hematology Oncology & Blood and Marrow Transplant
Author Profile25 Aug 2024Submitted to Pediatric Blood & Cancer 25 Aug 2024Submission Checks Completed
25 Aug 2024Assigned to Editor
26 Aug 2024Review(s) Completed, Editorial Evaluation Pending
28 Aug 2024Editorial Decision: Revise Minor
05 Sep 2024Submission Checks Completed
05 Sep 2024Assigned to Editor
05 Sep 20241st Revision Received
06 Sep 2024Review(s) Completed, Editorial Evaluation Pending
09 Sep 2024Editorial Decision: Revise Minor
25 Sep 2024Submission Checks Completed
25 Sep 2024Assigned to Editor
25 Sep 20242nd Revision Received
26 Sep 2024Review(s) Completed, Editorial Evaluation Pending
30 Sep 2024Editorial Decision: Revise Minor
03 Oct 2024Submission Checks Completed
03 Oct 2024Assigned to Editor
03 Oct 20243rd Revision Received
04 Oct 2024Review(s) Completed, Editorial Evaluation Pending
04 Oct 2024Editorial Decision: Accept
